Monitoring of lopinavir and ritonavir in peripheral blood mononuclear cells, plasma, and ultrafiltrate using a selective and highly sensitive LC/MS/MS assay

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 850, Issue 1-2, 2007, Pages 249-258

  Ehrhardt, Manuela ^a   Möck, Marion ^a   Haefeli, Walter E ^a   Mikus, Gerd ^a   Burhenne, Jürgen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Kaletra ; LC MS MS; Lopinavir; PBMC; Protein binding; Ritonavir

Indexed keywords

CELLS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMAS; ULTRAFILTRATION;

LOPINAVIR; PBMC; PROTEIN BINDING; RITONAVIR;

DRUG PRODUCTS;

LOPINAVIR PLUS RITONAVIR; SAQUINAVIR;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ISOLATION; DRUG MONITORING; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

HIV PROTEASE INHIBITORS; HUMANS; PYRIMIDINONES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RITONAVIR; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; ULTRAFILTRATION;

EID: 34247326493     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.11.037     Document Type: Article

References (32)

1. Palella F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., Aschman D.J., and Holmberg S.D. N. Engl. J. Med. 338 (1998) 853
2. Ernest C.S., Hall S.D., and Jones D.R. J. Pharmacol. Exp. Ther. 312 (2005) 583
3. Lee C.G., Gottesman M.M., Cardarelli C.O., Ramachandra M., Jeang K.T., Ambudkar S.V., Pastan I., and Dey S. Biochemistry 37 (1998) 3594
4. Aarnoutse R.E., Schapiro J.M., Boucher C.A.B., Hekster Y.A., and Burger D.M. Drugs 63 (2003) 741
5. van Heeswijk R.P.G. Ther. Drug Monit. 24 (2002) 323
6. Roberts N.A., Craig J.C., and Sheldon J. AIDS 12 (1998) 453
7. Fraaij P.L.A., Rakhmanina N., Burger D.M., and de Groot R. Ther. Drug Monit. 26 (2004) 122
8. Burger D., Hugen P., Reiss P., Gyssens I., Schneider M., Kroon F., Schreij G., Brinkman K., Richter C., Prins J., Aarnoutse R., and Lange J. AIDS 17 (2003) 1157
9. Back D.J., and Khoo S.H. Br. J. Clin. Pharmacol. 55 (2003) 473
10. Boffito M., Acosta E., Burger D., Fletcher C.V., Flexner C., Garaffo R., Gatti G., Kurowski M., Perno C.F., Peytavin G., Regazzi M., and Back D. Antivir. Ther. 10 (2005) 469
11. Hugen P.W.H., Burger D.M., Aarnoutse R.E., Baede P.A., Nieuwkerk P.T., Koopmans P.P., and Hekster Y.A. Ther. Drug Monit. 24 (2002) 579
12. Ray J.E., Marriott D., Bloch M.T., and McLachlan A.J. Br. J. Clin. Pharmacol. 60 (2005) 291
13. Boffito M., Hoggard P.G., Lindup W.E., Bonora S., Sinicco A., Khoo S.H., Perri G.D., and Back D.J. Ther. Drug Monit. 26 (2004) 35
14. Koeplinger K.A., Raub T.J., Padbury G.E., and Zhao Z. J. Pharm. Biomed. Anal. 19 (1999) 399
15. Meaden E.R., Hoggard P.G., Newton P., Tjia J.F., Adam D., Cornforth D., Lloyd J., Williams I., Back D.J., and Khoo S.H. Antimicrob. Agents Chemother. 50 (2002) 583
16. Colombo S., Beguin A., Telenti A., Biollaz J., Buclin T., Rochat B., and Decosterd L.A. J. Chromatogr. B 819 (2005) 259
17. Huang Y., Zurlinden E., Lin E., Li X., Tokumoto J., Golden J., Murr A., Engstrom J., and Conte J. J. Chromatogr. B 799 (2004) 51
18. Rouzes A., Berthoin K., Xuereb F., Djabarouti S., Pellegrin I., Pellegrin J.L., Coupet A.C., Augagneur S., Budzinski H., Saux M.C., and Breilh D. J. Chromatogr. B 813 (2004) 209
19. Pelerin H., Compain S., Duval X., Gimenez F., Benech H., and Mabondzo A. J. Chromatogr. B 819 (2005) 47
20. Burhenne J., Riedel K.D., Martin-Facklam M., Mikus G., and Haefeli W.E. J. Chromatogr. B 784 (2003) 233
21. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, May 2001. Available from: URL: http://www.fda.gov/cder/guidance/4252fnl.htm (accessed August 31, 2006).
22. Shah V.P., Midha K.K., Findlay J.W., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551
23. Furman P.A., Fyfe J.A., St Clair M.H., Weinhold K., Rideout J.L., Freeman G.A., Lehrman S.N., Bolognesi D.P., Broder S., and Mitsuya H. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 8333
24. Condra J.H., Schleif W.A., Blahy O.M., Gabryelski L.J., Graham D.J., Quintero J.C., Rhodes A., Robbins H.L., Roth E., Shivaprakash M., Titus D., Yang T., Teppler H., Squires K.E., Deutsch P.J., and Emini E.A. Nature 374 (1995) 569
25. Hoggard P.G., and Owen A. J. Antimicrob. Chemother. 51 (2003) 493
26. Breilh D., Pellegrin I., Rouzes A., Berthoin K., Xuereb F., Munck M., Budzinski H., Fleuery H., Saux M.C., and Pellegrin J.L. AIDS 18 (2004) 1305
27. Hennessy M., Clarke S., Spiers J.P., Mulcahy F., Kelleher D., Meadon E., Maher B., Bergin C., Khoo S., Tjia J., Hoggard P., Back D., and Barry M. Antivir. Ther. 8 (2003) 191
28. Crommentuyn K.M.L., Mulder J.W., Mairuhu A.T.A., van Gorp E.C., Meenhorst P.L., Huitema A.D.R., and Beijnen J.H. Antivir. Ther. 9 (2004) 779
29. Su Y., Zhang X., and Sinko P.J. Mol. Pharm. 1 (2004) 49
30. Polli J.W., Wring S.A., Humphreys J.E., Huang L., Morgan J.B., Webster L.O., and Singh C.S. J. Pharmacol. Exp. Ther. 299 (2001) 620
31. Chandler B., Almond L., Ford J., Hoggard P., Khoo S., and Back D. JAIDS 33 (2003) 551
32. Vishnuvardhan D., Moltke L., Richter C., and Greenblatt D.J. AIDS 17 (2003) 1092